The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$5.64

Today's change-0.02 -0.35%
Updated December 2 1:27 PM EST. Delayed by at least 15 minutes.
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$5.64

Today's change-0.02 -0.35%
Updated December 2 1:27 PM EST. Delayed by at least 15 minutes.

Nuvo Pharmaceuticals Inc down $0.02

Nuvo Pharmaceuticals Inc closed lower Friday, dropping $0.02 or 0.35% to $5.64. Over the last five days, shares have gained 0.71% and 8.25% year to date. Shares have underperformed the S&P TSX by 26.99% during the last year.

Key company metrics

  • Trailing P/E11.11×
  • P/E 1 year forward8.48×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.51
Updated December 2 1:27 PM EST. Delayed by at least 15 minutes.

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue6888
Total other revenue--------
Total revenue6888
Gross profit3555
Total cost of revenue3333
Total operating expense4658
Selling / general / administrative1223
Research & development0002
Depreciation / amortization0000
Interest expense (income), net operating00--0
Unusual expense (income)------0
Other operating expenses, total--------
Operating income1220
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets00--0
Other--------
Income before tax1220
Income after tax1220
Income tax, total0000
Net income12-10
Total adjustments to net income--------
Net income before extra. items1220
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1220
Inc. avail. to common incl. extra. items12-10
Diluted net income12-10
Dilution adjustment00----
Diluted weighted average shares12121111
Diluted EPS excluding extraordinary itemsvalue per share0.100.210.170.03
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.100.210.170.03